pubmed.ncbi.nlm.nih.gov

Sphingolipid metabolism and cell growth regulation - PubMed

Review

Sphingolipid metabolism and cell growth regulation

S Spiegel et al. FASEB J. 1996 Oct.

Abstract

Sphingolipids have been implicated in the regulation of cell growth, differentiation, and programmed cell death. The current paradigm for their action is that complex sphingolipids such as gangliosides interact with growth factor receptors, the extracellular matrix, and neighboring cells, whereas the backbones--sphingosine and other long-chain or "sphingoid" bases, ceramides, and sphingosine 1-phosphate--activate or inhibit protein kinases and phosphatases, ion transporters, and other regulatory machinery. Tumor necrosis factor-alpha, interleukin 1beta, and nerve growth factor, for example, induce sphingomyelin hydrolysis to ceramide. Other agonists, such as platelet-derived growth factor, trigger further hydrolysis of ceramide to sphingosine and activate sphingosine kinase to form sphingosine 1-phosphate. These metabolites either stimulate or inhibit growth and may be cytotoxic (in some cases via induction of apoptosis), depending on which products are formed (or added exogenously), the cellular levels (and possibly intracellular localization), and the cell type. In Swiss 3T3 cells, for example, sphingosine and sphingosine 1-phosphate are growth stimulatory at low concentrations via calcium mobilization from intracellular stores and activation of the mitogen-activated protein kinase (MAP kinase) pathway and transcription factors (AP-1), but are toxic at high concentrations. High levels of endogenous sphingoid bases are also produced by inhibition of ceramide synthase by fumonisins, mycotoxins produced by Fusarium moniliforme, resulting in growth stimulation or toxicity. Thus, sphingolipid metabolites appear to serve as second messengers for growth factors, cytokines, and other "physiological" agonists and, when elevated abnormally, to lead to disease.

PubMed Disclaimer

Cited by

ATP-independent glucose stimulation of sphingosine kinase in rat pancreatic islets.
Mastrandrea LD, Sessanna SM, Del Toro A, Laychock SG. Mastrandrea LD, et al. J Lipid Res. 2010 Aug;51(8):2171-80. doi: 10.1194/jlr.M000802. Epub 2010 Apr 5. J Lipid Res. 2010. PMID: 20371493 Free PMC article.
Agent Orange Reviewed: Potential Role in Peripheral Neuropathy and Neurodegeneration.
de la Monte SM, Goel A. de la Monte SM, et al. J Mil Veterans Health. 2022 Apr;30(2):17-26. J Mil Veterans Health. 2022. PMID: 36785586 Free PMC article.
Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death.
Mandala SM, Thornton R, Galve-Roperh I, Poulton S, Peterson C, Olivera A, Bergstrom J, Kurtz MB, Spiegel S. Mandala SM, et al. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7859-64. doi: 10.1073/pnas.120146897. Proc Natl Acad Sci U S A. 2000. PMID: 10859351 Free PMC article.
Identification of novel functional inhibitors of acid sphingomyelinase.
Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P. Kornhuber J, et al. PLoS One. 2011;6(8):e23852. doi: 10.1371/journal.pone.0023852. Epub 2011 Aug 31. PLoS One. 2011. PMID: 21909365 Free PMC article.
Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
Stam JC, Michiels F, van der Kammen RA, Moolenaar WH, Collard JG. Stam JC, et al. EMBO J. 1998 Jul 15;17(14):4066-74. doi: 10.1093/emboj/17.14.4066. EMBO J. 1998. PMID: 9670021 Free PMC article.

Sphingolipid metabolism and cell growth regulation - PubMed